Vertex Pharmaceuticals
VRTX
VRTX
489 hedge funds and large institutions have $20.9B invested in Vertex Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 188 increasing their positions, 178 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more capital invested
Capital invested by funds: $20.7B → $20.9B (+$226M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
489
Holding in Top 10
4
Calls
$95.6M
Puts
$87.9M
Top Buyers
| 1 | +$192M | |
| 2 | +$143M | |
| 3 | +$62M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$52.3M |
| 5 |
Morgan Stanley
New York
|
+$46.2M |
Top Sellers
| 1 | -$111M | |
| 2 | -$100M | |
| 3 | -$51M | |
| 4 |
O
OrbiMed
New York
|
-$50.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$46.1M |